Abstract 12979: NPA7: First-in-Class Bispecific GC-A/MasR Activating Peptide That Enhances Cardiorenal Function and Suppresses Renin and Aldosterone In Vivo via Subcutaneous Delivery

Introduction: Bispecific drugs have emerged as highly efficacious medicines as they are designed to target two separate signaling pathways. We engineered a bispecific peptide NPA7 to co-activate th...